Nektar Therapeutics rises after reports of Eli Lilly’s buyout interest and strong Phase IIb results for REZPEG. With FDA Fast...
Read moreDetailsNovavax faces pressure from a major shareholder Shah Capital to explore a sale as it struggles with weak revenue, poor...
Read moreDetailsDocGo buys virtual care platform SteadyMD in an all-cash deal, boosting its digital health reach. The move excites investors as...
Read moreDetailsMister Car Wash expands in Texas with five new Whistle Express locations, strengthening its local network, boosting efficiency, and focusing...
Read moreDetailsIBM shares took a dive on Thursday despite stronger-than-expected third-quarter earnings and revenue. Investors have turned their focus to signs...
Read moreDetailsMcEwen Mining is acquiring Canadian Gold Corp. in an all-stock deal, adding the high-grade Tartan Lake project in Manitoba to...
Read moreDetailsChatGPT said: Talkspace acquires Wisdo Health to strengthen its AI-driven behavioral health platform, adding peer-based support and expanding reach across...
Read moreDetailsThe U.S. rare earths sector is suddenly back in focus as investors rush to find the next big play in...
Read moreDetailsJack in the Box shares plunged after selling Del Taco for just $115 million—an 80% markdown from its 2021 purchase—raising...
Read moreDetailsHealthStream acquires Virsys12 for $17M, expanding into the payer market with V12 Enterprise® and strengthening its credentialing suite as it...
Read moreDetailsThese Next Steps are EXTREMELY IMPORTANT because the only way to get our Featured Top Stock Alerts is to reply back to the message you just received by answering YES.
CLICK HERE TO REPLY BACK
YES ON YOUR CELL PHONE
To make sure you are in, please check your cell phone for a message from 16462224464 (make sure you save that number on your contacts under "StockTips") If you don't see the message check "Unknown Senders" on your phone.
If you did not receive the text message on your cell phone, then grab your phone right now and text the word "MOMO" to "16462224464"
© 2022 OpenEquity Research - Investment-Grade Research for the rest of us.
© 2022 OpenEquity Research - Investment-Grade Research for the rest of us.